Month: February 2024

BOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 11:30 a.m. ET in New York. A live webcast will be available in the investor section of the company’s website at www.vervetx.com. The webcast will be archived for 30 days following the presentation. About Verve Therapeutics Verve Therapeutics, Inc. is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from chronic...

METTAWA, Ill., Feb. 01, 2024 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC), today, released its fourth quarter and full year 2023 financial results.  A complete and full-text financial results press release is available on the Company’s website at https://ir.brunswick.com.  The results will also be available on the SEC’s website with the Form 8-K filing of the release at http://goo.gl/wJQN1. The Company will hold a conference call at 10 a.m. CST/ 11 a.m. EST, today, Thursday, February 1, 2024, hosted by David M. Foulkes, chief executive officer, Ryan M. Gwillim, executive vice president and chief financial officer and Neha Clark, senior vice president, enterprise finance.  A copy of the presentation to be used on this call will be available when the results are released as noted above. Security analysts and investors wishing...

Record 2023 Results Strengthen the Foundation for Continuous GrowthNet revenues of Euro 5,970 million, up 17.2% versus prior year, with total shipments of 13,663 units up 3.3% versus FY 2022 Adjusted EBIT(1) of Euro 1,617 million, up 31.8% versus prior year, with adjusted EBIT(1) margin of 27.1% Adjusted net profit(1) of Euro 1,257 million and adjusted diluted EPS(1) at Euro 6.90 Adjusted EBITDA(1) of Euro 2,279 million, up 28.5% versus prior year, with adjusted EBITDA(1) margin of 38.2% Industrial free cash flow(1) generation of Euro 932 million“2023 was a very successful year, during which we strengthened our brand through a number of achievements reflected in our unprecedented financial results. For the first time, our net profit, up 34%, exceeded 1 billion Euro and the annual EBITDA margin rose to 38.2%,” said Benedetto Vigna,...

LOS ANGELES, Feb. 01, 2024 (GLOBE NEWSWIRE) — Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter ended December 31, 2023. Financial Highlights for the Quarter Ended December 31, 2023Total investment income was $98.0 million ($1.26 per share) for the first fiscal quarter of 2024, as compared with $101.9 million ($1.32 per share) for the fourth fiscal quarter of 2023. Adjusted total investment income was $98.0 million ($1.26 per share) for the first fiscal quarter, as compared with $102.2 million ($1.32 per share) for the fourth fiscal quarter of 2023. The decrease for the quarter was primarily driven by lower interest income, mainly due to an increase in non-accrual investments, partially...

Coherent will showcase its full suite of medical device manufacturing systems at MDM West, at the Anaheim Convention Center in California, Feb. 6-8.Coherent’s ExactWeld 410 system for precision welding of medical devicesThe ExactWeld 410 from Coherent is a new system that excels at the most demanding requirements for precision welding of medical devices. The system is built for optimal cost of ownership with a small footprint that fits into production lines when floor space is a premium, supports a broad range of application and production needs, and provides traceability of process quality.PITTSBURGH, Feb. 01, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a leader in industrial lasers for precision manufacturing, today introduced the ExactWeld 410 laser welding system for medical device manufacturing.Medical...

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a public reminder to healthcare providers that PEDMARK (sodium thiosulfate injection) is not substitutable with other sodium thiosulfate products as explicitly directed in its prescribing label. PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors. The FDA stated in the public communication that it is aware that some providers may be preparing other sodium thiosulfate (STS) products for patient use in...

SYDNEY, Australia, Feb. 01, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “Iris Energy”, or the “Company”), a leading owner and operator of institutional-grade, highly efficient Bitcoin mining data centers powered by 100% renewable energy, today announced that it will release its financial results for the three and six-months ended December 31, 2023, on Thursday, February 15, 2024 USA Eastern Time and will host a conference call beginning at 5:00 p.m. USA Eastern Time. The webcast will be recorded, and the replay will be accessible shortly after the event at https://investors.irisenergy.co/events-and-presentationsWebcast and Conference DetailsTime & Date: 5:00 p.m. USA Eastern Time, Thursday, February 15, 2024    9:00 a.m. Australian Eastern Daylight Time, Friday, February...

HAMILTON, BERMUDA, February 1, 2024 – DHT Holdings, Inc. (NYSE:DHT) (the “Company”) today announced the appointment of Ms. Ana Zambelli to the Board of Directors, effective February 1, 2024. Ms. Ana Zambelli brings significant experience with more than 20 years in the energy sector in operational, commercial and finance roles. Ms. Zambelli served as a Managing Director in Brookfield’s Private Equity Group, responsible for business operations in Brazil, as Chief Commercial Officer at Maersk Drilling, Managing Director at Transocean, and President of the Brazilian division of Schlumberger. Ms. Zambelli is an experienced board member and previously served at Board of Directors of BRK Ambiental, Unidas, Aldo Solar, Petrobras, Braskem, and was the founder and leader of the Diversity Committee at the Brazilian Petroleum Institute (IBP)...

8,250 vehicles delivered in January 2024, a 58% increase year-over-year2,478 units of X9 delivered in the first month of customer deliveriesGUANGZHOU, China, Feb. 01, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced its vehicle delivery results for January 2024. In January 2024, XPENG recorded monthly deliveries of 8,250 Smart EVs, representing a 58% increase year-over-year. In early January, the Company launched its X9 Ultra Smart Large Seven-seater MPV, followed by immediate deliveries across more than 100 cities in China. In January, 2,478 X9s were delivered and orders for X9 Max trim accounted for approximately 70% of total X9 orders. The X9 has showcased its outstanding product competitiveness and cutting-edge...

AppTech’s Patented Technology Advances the Future of Digital Financial Services Through Strategic Collaborations CARLSBAD, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company powering frictionless commerce, today announced the Company’s licensee PayToMe.co, an award-winning Digital Payment Platform, has successfully collaborated and integrated Plaid’s technology into their platform, marking a significant advancement in AppTech’s intellectual property and licensing business. This milestone enhances PayToMe.co’s offerings, including secure financial data access, extensive network coverage, and intuitive user interface, aligning with AppTech’s commitment to fostering Fintech innovation. Luke D’Angelo, Chairman & CEO of AppTech,...